Myomo (MYO) Operating Leases (2020 - 2025)

Myomo (MYO) posted Operating Leases of $7.7 million for Q4 2025, down 2.13% on a QoQ basis from $7.8 million in Q3 2025, and up 4.18% year-over-year from $7.4 million in Q4 2024.

Myomo (MYO) Operating Leases (2020 - 2025) Analysis & Trends

Myomo's Operating Leases history runs 6 years deep, the most recent figure standing at $7.7 million for Q4 2025.

  • Quarterly Operating Leases rose 4.18% year-over-year to $7.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.7 million (up 4.18% YoY) and the FY2025 annual result came in at $7.7 million, up 4.18% from the prior year.
  • Operating Leases was $7.7 million for Q4 2025 at Myomo, down from $7.8 million in the prior quarter.
  • Across five years, Operating Leases topped out at $8.0 million in Q2 2025 and bottomed at $29165.0 in Q3 2024.
  • A 5-year average of $2.1 million and a median of $365175.5 in 2021 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2024 — Operating Leases slumped 88.48% — and 2025, when it surged 26756.58%.
  • Myomo's Operating Leases stood at $401622.0 in 2021, then plunged by 50.15% to $200207.0 in 2022, then plunged by 42.48% to $115160.0 in 2023, then jumped by 6289.53% to $7.4 million in 2024, then advanced by 4.18% to $7.7 million in 2025.
  • Business Quant data shows MYO's Operating Leases at $7.7 million in Q4 2025, $7.8 million in Q3 2025, and $8.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.19 Bn 173.90 Bn 6.27 Bn
2 Stryker 128.53 Bn 125.65 Bn 3.81 Bn
3 Medtronic 107.77 Bn 98.55 Bn 6.41 Bn
4 Boston Scientific 67.72 Bn 66.27 Bn 3.61 Bn
5 Edwards Lifesciences 48.21 Bn 44.54 Bn 1.29 Bn
6 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn
7 GE HealthCare Technologies 28.33 Bn 26.05 Bn 1.98 Bn
8 Smith & Nephew 26.76 Bn 26.18 Bn -
9 Koninklijke Philips 25.27 Bn 22.15 Bn 2.07 Bn
10 Myomo 44.70 Mn 25.73 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 7.67 Mn
Sep 30, 2025 7.83 Mn
Jun 30, 2025 7.97 Mn
Mar 31, 2025 7.50 Mn
Dec 31, 2024 7.36 Mn
Sep 30, 2024 29,165.00
Jun 30, 2024 47,338.00
Mar 31, 2024 64,599.00
Dec 31, 2023 115,160.00
Sep 30, 2023 253,210.00
Jun 30, 2023 139,657.00
Mar 31, 2023 169,770.00
Dec 31, 2022 200,207.00
Sep 30, 2022 220,901.00
Jun 30, 2022 328,729.00
Mar 31, 2022 453,073.00
Dec 31, 2021 401,622.00
Sep 30, 2021 474,188.00
Jun 30, 2021 562,887.00
Mar 31, 2021 644,107.00